Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Total Debt (2014 - 2023)

Updated

Grace Therapeutics' Total Debt came in at $24,000 for fiscal Q3 2024 (quarter ended Dec 31, 2023).

Analysis

Grace Therapeutics (GRCE) Total Debt (2014 - 2023) Analysis & Trends

At the end of FY2023 (ended Mar 31, 2023), Grace Therapeutics' Total Debt was $75,000.

  • Total Debt carries a four-year compound annual growth rate of -51.5% (FY2019 to FY2023).
  • Going back by fiscal year, Total Debt was $1.36 million in FY2019.
  • The fiscal Q3 2024 figure represents the lowest quarterly Total Debt since fiscal Q1 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 49.50 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 44.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 80.90 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 53.78 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -5.53 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 54.01 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 26.23 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 62.67 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 24,000.00
Mar 31, 2023 75,000.00
Mar 31, 2019 1.36 Mn
Jun 30, 2018 -26,404.73
Aug 31, 2014 66,174.00
API Access

Grace Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=GRCE&period=max&api_key=YOUR_API_KEY